Navigation Links
Chem Rx Corporation Schedules 2008 Annual Meeting Date

LONG BEACH, N.Y., Oct. 31 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of institutional pharmacy services, today announced that its 2008 annual meeting of stockholders is planned to be held on Thursday, December 18, 2008. The meeting is scheduled for 10:00 a.m. local time at the offices of Paramount BioSciences, LLC, located at 787 Seventh Avenue, 48th Floor, New York, New York 10019. Stockholders of record as of the close of business on November 3, 2008 will be entitled to vote at the meeting or any adjournment of the meeting. Any stockholder that intends to present a proposal for inclusion in the Company's proxy materials for the 2008 Annual Meeting must submit the proposal, in accordance with Securities Exchange Act of 1934 Rule 14a-8, not later than the close of business on Thursday, November 20, 2008.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx Corporation is a leading provider of institutional pharmacy services in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, Pennsylvania, and Florida. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Through its services, Chem Rx provides more than 67,500 institutional residents with prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx's filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.


Steven C. Silva

President and Chief Operating Officer

Chem Rx Corporation


Stephanie Carrington/Ben Carmichael

The Ruth Group

646-536-7017 / 7013

SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Torchmark Corporation Declares Dividend
2. Baxa Corporation Launches The Virtual Compounder(TM)
3. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
4. HLTH Corporation Announces Third Quarter Financial Results
5. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
6. Deloitte Names Heska Corporation to Colorado Technology Fast 50
7. AMERIGROUP Corporation to Present at the 17th Annual Credit Suisse Healthcare Conference on November 13
8. Webcast Alert: Air Methods Corporation Announces Third Quarter 2008 Financial Results
9. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
10. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
11. Berger & Montague Announces Class Action Lawsuit Against Elan Corporation
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Purdue ... in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and ... “Ever True” capital campaign. , The investment will result in cohesive efforts across ...
(Date:10/13/2015)... ... 2015 , ... Sir Grout of Greater Boston donated an expansive, seven room ... McDonald House Charities® (RMHC®). This donation was made in an effort to give back ... its inception. , “We believe strongly in the Ronald McDonald House Charities, and they ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... in the United States, today announced the release of its limited edition holiday ... Cranberry Cocktail Agua Fresca. All feature the unique flavor combinations and delicious taste ...
(Date:10/13/2015)... ... , ... According to an article published October 5th by the ... lose weight with a bariatric procedure are much less likely to develop endometrial cancer, ... anywhere from 40 to 50 percent of all endometrial cancer cases are caused by ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Symposium Chairman, Dr. ... 19th annual Dallas Cosmetic Symposium to be held March 2nd and 3rd, 2016. The ... afterwards, draws plastic surgeons and cosmetic physicians from around the world. , Key topics ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... SHANGHAI , Oct. 13, 2015 ... R&D capability and technology platform company serving the ... that it has launched a mobile version of ... allow researchers to access oncology models and data ... clients anywhere and at any time to identify ...
(Date:10/13/2015)... , Oct. 13, 2015  The ... Harvard University today announced the launch of ... Ultivue will introduce imaging reagents providing ... to those of expensive specialized instruments. The ... Harvard,s Office of Technology Development (OTD) ...
(Date:10/13/2015)... , October 13, 2015 --> ... ,What can be expected from the Asthma and COPD Therapies ... rates? Visiongain ,s brand new report shows you potential ... ,  ,Our 309-page report provides 260 tables, charts, and graphs. ... future market prospects. Our new study lets you assess forecasted ...
Breaking Medicine Technology: